Stocks › GH
Guardant Health, Inc.
GH·Nasdaq·
United States·USD
United States·USD$170.69
-16.53 (-8.83%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
GH
Guardant Health, Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
GHS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of GH by members of U.S. Congress · 11 on record · 1 in the last 12 months
Whale Activity
Position changes in GH reported for 2026-06-30 by 28 tracked institutional filers
- Increased8
- New0
- Held1
- Decreased5
- Closed1
- No prior filing13
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 7.6M | $1.14B | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.8M | $863.6M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.4M | $817.0M | decreased |
| TWO SIGMA INVESTMENTS, LP | 3.7M | $558.0M | decreased |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2.6M | $394.4M | — |
| D. E. Shaw & Co., Inc. | 104.5M | $263.1M | increased |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.6M | $243.7M | — |
| MILLENNIUM MANAGEMENT LLC | 1.6M | $243.4M | increased |
| CITADEL ADVISORS LLC | 1.4M | $217.5M | increased |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.3M | $196.7M | — |
| D. E. Shaw & Co., Inc. | 1.3M | $188.4M | increased |
| Point72 Asset Management, L.P. | 920.8K | $138.1M | increased |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by GH insiders, by quarter · Form 4
Recent Insider Transactions
2,096 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Tariq MusaDirector · Director | Sale | −116 | $175.00 | $20K | Sep 16, 2026 | Form 4 ↗ |
| Krognes Steve E.Director · Director | Sale | −971 | $177.48 | $172K | Sep 16, 2026 | Form 4 ↗ |
| Krognes Steve E.Director · Director | Sale | −3,300 | $175.42 | $579K | Sep 16, 2026 | Form 4 ↗ |
| Krognes Steve E.Director · Director | Sale | −1,300 | $176.34 | $229K | Sep 16, 2026 | Form 4 ↗ |
| Krognes Steve E.Director · Director | Sale | −1,103 | $174.46 | $192K | Sep 16, 2026 | Form 4 ↗ |
| Azar Alex M IIDirector · Director | Sale | −826 | $175.00 | $145K | Sep 16, 2026 | Form 4 ↗ |
| Chudova DaryaChief Technology Officer | Sale | −7,738 | $178.00 | $1.4M | Sep 15, 2026 | Form 4 ↗ |
| Kalia KumudChief Information Officer | Sale | −4,000 | $158.05 | $632K | Sep 11, 2026 | Form 4 ↗ |
| Talasaz AmirAliCo-Chief Executive Officer · Director | Sale | −9,023 | $168.20 | $1.5M | Aug 21, 2026 | Form 4 ↗ |
| Talasaz AmirAliCo-Chief Executive Officer · Director | Sale | −7,589 | $170.29 | $1.3M | Aug 21, 2026 | Form 4 ↗ |
| Talasaz AmirAliCo-Chief Executive Officer · Director | Sale | −20.9K | $169.16 | $3.5M | Aug 21, 2026 | Form 4 ↗ |
| Tariq MusaDirector · Director | Sale | −116 | $156.45 | $18K | Aug 17, 2026 | Form 4 ↗ |
| Monroe Terilyn J.Chief People Officer | Sale | −9,934 | $164.27 | $1.6M | Aug 12, 2026 | Form 4 ↗ |
| Monroe Terilyn J.Chief People Officer | Sale | −400 | $167.92 | $67K | Aug 12, 2026 | Form 4 ↗ |
| Monroe Terilyn J.Chief People Officer | Sale | −3,704 | $163.41 | $605K | Aug 12, 2026 | Form 4 ↗ |
| Monroe Terilyn J.Chief People Officer | Sale | −19.0K | $165.16 | $3.1M | Aug 12, 2026 | Form 4 ↗ |
| Monroe Terilyn J.Chief People Officer | Sale | −13.2K | $166.11 | $2.2M | Aug 12, 2026 | Form 4 ↗ |
| Freeman ChrisChief Commercial Officer | Sale | −7,365 | $168.79 | $1.2M | Aug 10, 2026 | Form 4 ↗ |
| Freeman ChrisChief Commercial Officer | Sale | −35.4K | $169.63 | $6.0M | Aug 10, 2026 | Form 4 ↗ |
| Freeman ChrisChief Commercial Officer | Sale | −3,463 | $167.38 | $580K | Aug 10, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding GH · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 4.0M | $600.1M | 0.03% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 2.9M | $433.4M | 0.23% | Jun 30, 2026 |
| iShares Russell 2000 ETF iSHARES TRUST | 3.0M | $280.2M | 0.39% | Mar 31, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 1.8M | $266.8M | 1.81% | Jun 30, 2026 |
| Franklin Dynatech Fund Franklin Custodian Funds | 1.8M | $262.6M | 0.87% | Jun 30, 2026 |
| FULLERTHALER BEHAVIORAL SMALL-CAP GROWTH Capitol Series Trust | 1.7M | $259.5M | 4.20% | Jun 30, 2026 |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 1.7M | $249.9M | 0.53% | Jun 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.5M | $228.1M | 0.23% | Jun 30, 2026 |
| VANGUARD U.S. GROWTH FUND VANGUARD WORLD FUND | 1.7M | $222.6M | 0.47% | May 31, 2026 |
| Eventide Gilead Fund MUTUAL FUND SERIES TRUST | 1.3M | $189.8M | 5.52% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list GH's shares (CUSIP 40131M109), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- T. Rowe Price Associates, Inc.SCHEDULE 13G/A · passive (13G) · 6.5M shares4.9%
Aug 14, 2026 · ↗ - BlackRock, Inc.SCHEDULE 13G/A · passive (13G) · 6.9M shares5.2%
Jul 28, 2026 · ↗ - T. Rowe Price Associates, Inc.SCHEDULE 13G · passive (13G) · 7.0M shares5.4%
May 15, 2026 · ↗ - Vanguard Capital ManagementSCHEDULE 13G · passive (13G) · 6.6M shares5.0%
Apr 30, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming guardant health as client
- TODD STRATEGY GROUPGUARDANT HEALTH, INC. · 2026 Q2 · HCR$80K
Filing ↗ - GUARDANT HEALTHGUARDANT HEALTH · 2026 Q2 · MMM, HCR$180K
Filing ↗ - IPOLICY SOLUTIONSGUARDANT HEALTH INC. · 2026 Q2 · MMM$16K
Filing ↗ - GUARDANT HEALTHGUARDANT HEALTH · 2026 Q1 · MMM, HCR$241K
Filing ↗ - TODD STRATEGY GROUPGUARDANT HEALTH, INC. · 2026 Q1 · HCR$80K
Filing ↗
Government Contracts
Federal awards to Guardant Health, Inc. · USAspending
No federal contract awards found for Guardant Health, Inc..
U.S. Patents
Recent USPTO applications naming Guardant Health, Inc.
No USPTO patent applications found for Guardant Health, Inc..
Annual Financials
From GH's 10-K filings · XBRL
No annual XBRL figures on record for GH. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in GH's price history.
About Guardant Health, Inc.
From SEC EDGAR company records
Industry (SIC 8071)Services-Medical Laboratories
SectorHealthcare
HeadquartersPALO ALTO, CA
IncorporatedDE
SEC CIK0001576280 ↗